RohamTZamanianMD

Pulmonology • Stanford, CA

Critical Care Medicine, Pleural Disease

Assistant Professor, Medicine - Pulmonary & Critical Care Medicine, Stanford University Medical Center

Join to view full profile

Dr. Zamanian is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Zamanian's full profile

Already have an account?

Office
300 Pasteur Dr
Stanford, CA 94305
Phone(650) 725-5495
Is this information wrong?

Education & Training

Stanford UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2005
University of California IrvineResidency, Internal Medicine, 1999 - 2002
University of California Irvine School of MedicineClass of 1999

Certifications & Licensure

CA State Medical License 2001 - 2021
American Board of Internal Medicine Pulmonary Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension Start of enrollment: 2013 May 01Boris Medarov, MD, Shilpa DeSouza, MD, David Ishizawar, MD, and Sonja Bartolome, MD
A Multi-center, Open-label, Single-arm, Phase 3b Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01Robert L Scott, MD, David Badesch, MD, Charles Burger, MD, James R Gossage, MD, Chad Miller, MD, Leslie Spikes, MD, Wesley McConnell, MD, Joseph Ojile, MD, William Michael Johnson, MD, Ilia Segal, MD, Shi...
Single-Center Randomized Controlled Phase II Study of Safety and Efficacy of FK-506 (Tacrolimus) in Pulmonary Arterial Hypertension Start of enrollment: 2012 Jul 01Zamanian, R.T.,Spiekerkoetter, E.F.
A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituximab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2010 Aug 01Arnez, G.,Badesch, D.B.,Culbreth, R.,DeWilde, C.,Gashouta, M.,Grace, E.,Hebda, S.,Ivanco, D.,Medsger, T.A.,Nicolls, M.,Patrizi, R.,Scott, V.,Shaw, A.,Thomas, M.,Wessman, K.
A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil), 2 FDA Approved Pulmonary Hypertension Medications Start of enrollment: 2010 Jul 01Zamanian, R.T.
Insulin Resistance in Pulmonary Arterial Hypertension Start of enrollment: 2008 Sep 01Zamanian, R.T.
Subcutaneous Elafin in Healthy Subjects Roham Zamanian, MD

Publications & Presentations

PubMed

Hemodynamic trajectories and outcomes in patients with pulmonary arterial hypertension
Myriam Amsallem, Shadi P. Bagherzadeh, David Boulate, Andrew J. Sweatt, Kristina Kudelko, Yon K. Sung, Jeffrey A. Feinstein, Elie Fadel, Olaf Mercier, André Y. Denault...> ;Pulmonary circulation. 2020 Dec 6
A Survey-based Estimate of COVID-19 Incidence and Outcomes among Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension and Imp...
Joshua Lee, Charles D. Burger, Genecelle B Delossantos, Daniel C. Grinnan, David D. Ralph, Sam G Rayner, John J. Ryan, Zeenat Safdar, Corey E. Ventetuolo, Roham T. Zam...> ;Annals of the American Thoracic Society. 2020 Dec 1
EmPHasis-10 as a Measure of Health-Related Quality of Life in Pulmonary Arterial Hypertension: data from PHAR.
Marissa Borgese, David B. Badesch, Todd M. Bull, Murali M. Chakinala, Teresa DeMarco, Jeremy Feldman, H. James Ford, Dan Grinnan, James R. Klinger, Lena Bolivar, Oksan...> ;European Respiratory Journal. 2020 Nov 26
Renin-Angiotensin-Aldosterone System Inhibitor Use and Mortality in Pulmonary Hypertension: Insights from the Veterans Affairs CART Database.
Tim Lahm, Edward Hess, Anna E. Barón, Thomas M. Maddox, Mary E. Plomondon, Gaurav Choudhary, Bradley A. Maron, Roham T. Zamanian, Peter J. Leary> ;Chest. 2020 Oct 5
Genetic Admixture and Survival in Diverse Populations with Pulmonary Arterial Hypertension
Jason H. Karnes, Howard W. Wiener, Tae Hwi Schwantes-An, Balaji Natarajan, Andrew J. Sweatt, Abhishek Chaturvedi, Amit Arora, Ken Batai, Vineet Nair, Heidi E. Steiner,...> ;American Journal of Respiratory and Critical Care Medicine. 2020 May 29
PENet-a scalable deep-learning model for automated diagnosis of pulmonary embolism using volumetric CT imaging.
Shih Cheng Huang, Tanay Kothari, Imon Banerjee, Christopher G. Chute, Robyn L. Ball, Norah Borus, Andrew C. Huang, Bhavik N. Patel, Pranav Rajpurkar, Jeremy Irvin, Jar...> ;NPJ digital medicine. 2020 Apr 24
Methamphetamine use association with pulmonary diseases: a retrospective investigation of hospital discharges in California from 2005 to 2011
Halley Tsai, Justin Lee, Haley Hedlin, Roham T. Zamanian, Vinicio A. de Jesus Perez> ;ERJ Open Research. 2019 Oct 1
Bone Morphogenetic Protein 9 Is a Mechanistic Biomarker of Portopulmonary Hypertension.
Ivana Nikolic, Lai Ming Yung, Peiran Yang, Rajeev Malhotra, Samuel D Paskin-Flerlage, Teresa Dinter, Geoffrey A. Bocobo, Kathleen E. Tumelty, Anthony J Faugno, Luca Tr...> ;American Journal of Respiratory and Critical Care Medicine. 2019 Apr 1
Discovery of distinct immune phenotypes using machine learning in pulmonary arterial hypertension
Andrew J. Sweatt, Haley Hedlin, Vidhya Balasubramanian, Andrew Hsi, Lisa K. Blum, William H. Robinson, Francois Haddad, Peter M. Hickey, Robin Condliffe, Allan Lawrie,...> ;Circulation Research. 2019 Mar 15
Low-grade albuminuria in pulmonary arterial hypertension.
Nickel, N. P., de Jesus Perez, V. A., Zamanian, R. T., Fessel, J. P., Cogan, J. D., Hamid, R., West, J. D., de Caestecker, M. P., Yang, H., Austin, E. D.> ;Pulmonary circulation. 2019 Jan 12
Clinical trial design and new therapies for pulmonary arterial hypertension.
Sitbon, O.,Gomberg-Maitland, M.,Granton, J.,Lewis, M. I.,Mathai, S. C.,Rainisio, M.,Stockbridge, N. L.,Wilkins, M. R.,Zamanian, R. T.,Rubin, L. J.> ;Eur. Respir. J.. 2018 Dec 14
Prevention of Deep Vein Thrombosis and Pulmonary Embolism in High-Risk Medical Patients.
Megan McCullough, Cyrus A. Kholdani, Roham T. Zamanian> ;Clinics in Chest Medicine. 2018 Sep 1
Exome data clouds the pathogenicity of genetic variants in Pulmonary Arterial Hypertension.
Yeganeh Abbasi, Javad Jabbari, Reza Jabbari, Charlotte Glinge, Seyed Bahador Izadyar, Edda Spiekerkoetter, Roham T. Zamanian, Jørn Carlsen, Jacob Tfelt-Hansen> ;Molecular Genetics & Genomic Medicine. 2018 Aug 6
The Role of Neutrophils and Neutrophil Elastase in Pulmonary Arterial Hypertension.
Shalina Taylor, Omar Dirir, Roham T. Zamanian, Marlene Rabinovitch, A. A. Roger Thompson> ;Frontiers in Medicine. 2018 Aug 3
Non-invasive right ventricular load adaptability indices in patients with scleroderma-associated pulmonary arterial hypertension.
Sarah French, Myriam Amsallem, Nadia Ouazani, S. Li, Kristina Kudelko, Roham T. Zamanian, Francois Haddad, Lorinda Chung> ;Pulmonary circulation. 2018 Jul 23
Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertensio...
Jason M. Elinoff, Richa Agarwal, Christopher Barnett, Raymond L. Benza, Michael J. Cuttica, Ahmed M. Gharib, Michael P. Gray, Paul M. Hassoun, Anna R. Hemnes, Marc Hum...> ;American Journal of Respiratory and Critical Care Medicine. 2018 Jul 15
H2 Receptor Antagonist Use and Mortality in Pulmonary Hypertension: Insight from the VA-CART Program.
Peter J. Leary, Edward Hess, Anna E. Barón, Kelley R. Branch, Gaurav Choudhary, Catherine L. Hough, Bradley A. Maron, David D. Ralph, John J. Ryan, Ryan J. Tedford, No...> ;American Journal of Respiratory and Critical Care Medicine. 2018 Jun 15
Drug-induced pulmonary arterial hypertension: a primer for clinicians and scientists.
Mark Orcholski, Ke Yuan, Charlotte Rajasingh, Halley Tsai, Elya A. Shamskhou, Navneet K. Dhillon, Norbert F. Voelkel, Roham T. Zamanian, Vinicio A. de Jesus Perez> ;American Journal of Physiology-lung Cellular and Molecular Physiology. 2018 Jun 1
Reply: Can treprostinil-induced early gastrointestinal side effects serve as predictors of pulmonary arterial hypertension prognosis?
Leary, P. J., Kolb, T. M., Maron, B. A., Tedford, R. J., Zamanian, R. T.> ;International journal of cardiology. 2018 May 20
Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire: Results of the SYMPHONY Trial.
Chin, K. M., Gomberg-Maitland, M., Channick, R. N., Cuttica, M. J., Fischer, A., Frantz, R. P., Hunsche, E., Kleinman, L., McConnell, J. W., McLaughlin, V. V., Miller,...> ;Chest. 2018 May 1
Endothelial nitric oxide synthase genotype is associated with pulmonary hypertension severity in left heart failure patients.
Julio D. Duarte, Mayank Kansal, Ankit A. Desai, Katherine Riden, Meghan J. Arwood, Alex A. Yacob, Thomas D. Stamos, Larisa H. Cavallari, Roham T. Zamanian, Sanjiv J. S...> ;Pulmonary circulation. 2018 Apr 1
Circulating plasmablasts are elevated and produce pathogenic anti-endothelial cell autoantibodies in idiopathic pulmonary arterial hypertension.
Blum, L. K., Cao, R. R., Sweatt, A. J., Bill, M., Lahey, L. J., Hsi, A. C., Lee, C. S., Kongpachith, S., Ju, C., Mao, R., Wong, H. H., Nicolls, M. R., Zamanian, R. T.,...> ;European journal of immunology. 2018 Jan 26
Upregulation of Human Endogenous Retrovirus-K Is Linked to Immunity and Inflammation in Pulmonary Arterial Hypertension
Toshie Saito, Kazuya Miyagawa, Shih-Yu Chen, Rasa Tamosiuniene, Lingli Wang, Orr Sharpe, Erik Samayoa, Daisuke Harada, Jan-Renier A.J. Moonen, Aiqin Cao, Pin-I Chen, J...> ;Circulation. 2017 Nov 14
4 citations
Features and Outcomes of Methamphetamine-associated Pulmonary Arterial Hypertension.
Zamanian, R. T., Hedlin, H., Greuenwald, P., Wilson, D. M., Segal, J. I., Jorden, M., Kudelko, K., Liu, J., Hsi, A., Rupp, A., Sweatt, A. J., Tuder, R. M., Berry, G. J...> ;American journal of respiratory and critical care medicine. 2017 Sep 22
1 citation
Randomised placebo-controlled safety and tolerability trial of FK506 (tacrolimus) for pulmonary arterial hypertension.
Spiekerkoetter, E., Sung, Y. K., Sudheendra, D., Scott, V., Del Rosario, P., Bill, M., Haddad, F., Long-Boyle, J., Hedlin, H., Zamanian, R. T.> ;The European respiratory journal. 2017 Sep 13
Join now to see all

Press Mentions

Hemodynamic Trajectories and Outcomes in Patients with Pulmonary Arterial HypertensionJanuary 09, 2021 22:58
Inhaled Nitric Oxide Scan for COVID-19 OxygenationMay 14, 2020 09:31
Inhaled Nitric Oxide Explored for COVID-19 OxygenationMay 14, 2020 09:31
Join now to see all